Oliver Mander was a panellist at the IoD conference focusing on this topic. The conference was conducted under ‘Chatham House rules’ – so while this article reflects the author’s thoughts, it does not necessarily reflect the full panel discussion. If you’re interested in some of the views from the panel, check out this LinkedIn video…
Read more
Annual Meeting Report, May 24th 2024 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 Change Revenue $925m $1,114m $1,298m $1,395m 7% Gross Profit $163m $202m $221m $229.9m 8% NPAT $30.9m $51.8m $32.1m $16.3m -49% Gross Profit Margin 18% 18% 17% 16% -3% Inventory Turnover 52.49 46.95 45.45 51.91 14% EPS1…
Read more
Annual Meeting Report, May 28th 2024 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 Change Revenue $88.6n $91.9m $67.1m $28.1m -57% Cost of Sales $43.3m $44.9m $20.5m $10.9m -54% Gross Profit $41.8m $43.4m $43.3m $19.9m -57% NPAT $30.1m $31.3m $31.1m $13.5m -57% Gross Profit Margin 51% 51% 71% 71% n/c…
Read more
Branch Event Report, May 7th 2024 On 7 May our guest speaker was Aaron Hockley, the Fund Manager for Vital Healthcare Property Trust. Lisa Parnell, Financial Controller for the trust, was also in attendance. Vital is the only specialist listed healthcare property trust on NZX with focus on developing health care real estate. Healthcare properties…
Read more
Annual Meeting Report, May 23rd 2024 Click here for NZSA Assessment and Voting Intentions Metric 2021 9period) 2022 2023 (6 months) 2024 Change Rental Income $498k $8.2m $5.7m $15.4m n/a EBITDA -$1.8m $2.6m $4.2m $12.5m n/a NPAT $15.1m $39.7m $5.3m $10.9m n/a Change in prop value $16.5m $35.3m $2.3m $7.4m n/a EPS1 $0.191 $0.343 $0.038…
Read more
Annual Meeting Report, May 23rd 2024 Click here for NZSA Assessment and Voting Intentions Metric 2020 AUD 2021 AUD 2022 AU 2023 AUD Change Revenue $3,224m $4,557m $5,168m $5,376m 10% EBITDA $266m $312m $414m $465.2m 12% NPAT $24m -$5m $191.2m $189.8m -1% EPS1 $0.045 $0.023 $0.22 $0.22 -1% PE Ratio 39 121 11 18 Capitalisation…
Read more
Annual Meeting Report, May 28th 2024 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 Change Revenue $87.5m $98.1m $135.1m $143m 6% EBITDA -$11.4m $6.5m $10.6m $13.3m 25% NPAT -$57.1m -$9.9m -$20.9m -$13.9m n/a Gross Profit Margin 57% 63% 63% 63% n/c EPS1 -$0.226 -$0.042 -$0.092 -$0.059 n/a PE Ratio n/a…
Read more
Annual Meeting Report, May 16th 2024 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 Change Revenue $701.8m $744.4m $785.9m $792.0m 1% Gross Profit $307.1m $340.6m $345.9m $335.8m -3% NPAT $73.2m $87.9m $88.4m $84.2m -5% Gross Profit Margin 44% 46% 44% 42% -4% EPS1 $0.329 $0.395 $0.397 $0.378 -5% Capitalisation $1,336m…
Read more
There’s been plenty of media and shareholder comment around the non-binding indicative offer received by Rakon Limited. A non-binding indicative offer (NBIO) was announced by Rakon to the market way back on December 11th 2023 – the announcement detailed the price ($1.70), that the bidder was ‘credible’ and disclosed that the NBIO had been received…
Read more
Annual Meeting Report, May 13th 2024 Click here for NZSA Assessment and Voting Intentions Presentations by the Chairman and CEO are both available on announcements to the NZX. These cover the arguments for delisting from NZX, and relisting on USX (Unlisted Securities Exchange.) Chair Phil Norman described the USX, a lower cost trading platform operating…
Read more
